Literature DB >> 19574338

As nature did not predict dialysis--what we can learn from FGF23 in end-stage renal disease?

Markus Ketteler, Patrick H Biggar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19574338     DOI： 10.1093/ndt/gfp323

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease.

Authors:  Sridevi Devaraj; Catherine Duncan-Staley; Ishwarlal Jialal
Journal:  Metab Syndr Relat Disord       Date:  2010-08-13       Impact factor: 1.894

Review 2.  Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes.

Authors:  Claudio Ronco; Mario Cozzolino
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.